SPC259
Natríumsirkonsýklósilíkat
Status:
VeittApplication date:
20.3.2019Application published:
15.4.2019Grant published:
15.11.2025
Max expiry date:
25.3.2033Medicine name:
LokelmaMedicine for children:
No
Timeline
Today
20.3.2019Application
15.4.2019Publication
15.11.2025Registration
25.3.2033Expires
Marketing license
IS authorization number:
EU/1/17/1173/001-002; EU/1/17/1173/003-004Date:
26.3.2018
Foreign authorization number:
EU/1/17/1173Date:
22.3.2018
Owner
Name:
ZS Pharma, IncAddress:
508 Wrangler Dr., Suite 100, Coppell US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2673237